Female Pattern Hair Loss Clinical Trial
Official title:
Multicenter, Randomised, Open Label, Comparative Clinical Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss (Including AGA Ludwig's Type 1-2)
Pantovigar - a high effective product designed primarily for the treatment of diffuse hair
loss in women as well as for the treatment of damaged hair, in the combined therapy can be
successfully applied in other types of alopecia.
The purpose of this study is to evaluate efficacy and tolerability of combination therapy
Pantovigar plus 2% minoxidil vs 2% minoxidil. To collect tolerability data for combined
treatment Pantovigar plus 2% Minoxidil course therapy.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00175617 -
Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
|
Phase 2 | |
| Completed |
NCT04090801 -
Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss
|
Phase 4 | |
| Withdrawn |
NCT02486848 -
Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
|
N/A | |
| Completed |
NCT00958750 -
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
|
Phase 3 | |
| Completed |
NCT02206802 -
Minoxidil Response Testing in Females With Female Pattern Hair Loss
|